Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 16:05 ET | Source: BioCardia, Inc.

BioCardia Reports First Quarter 2025 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
May 09, 2025 16:28 ET | Source: BioCardia, Inc.

BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025

SUNNYVALE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
March 31, 2025 13:39 ET | Source: BioCardia, Inc.

BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today

SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
March 26, 2025 16:30 ET | Source: BioCardia, Inc.

BioCardia Reports 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
March 21, 2025 08:30 ET | Source: BioCardia, Inc.

BioCardia to Host 2024 Financial Results and Corporate Update Conference Call on March 31, 2025

SUNNYVALE, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
November 13, 2024 16:05 ET | Source: BioCardia, Inc.

BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
November 06, 2024 07:00 ET | Source: BioCardia, Inc.

BioCardia to Host Q3 2024 Corporate Update and Financial Results Conference Call on November 13, 2024

SUNNYVALE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
August 13, 2024 16:30 ET | Source: BioCardia, Inc.

BioCardia Reports Second Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
May 14, 2024 16:02 ET | Source: BioCardia, Inc.

BioCardia Reports First Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
May 09, 2024 07:00 ET | Source: BioCardia, Inc.

BioCardia to Host Q1 2024 Financial Results and Corporate Update Conference Call on May 14, 2024

SUNNYVALE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...

Next Page keyboard_arrow_right